Use of aerosol therapy in patients under mechanical ventilation in the ICU
1 Intern Physician, Universidad Autónoma de Bucaramanga, Colombia. 0000-0002-0652-4572
2 Fourth Year Resident of Anesthesiology, Universidad San Carlos de Guatemala.
3 Medical Student, Universidad del Rosario, Bogotá, Colombia.
4 General Physician, Universidad de Ciencias Aplicadas y Ambientales, Bogotá, Colombia.
5 General Physician, Universidad Industrial de Santander, Colombia.
6 Intern Physician, Universidad Autónoma de Bucaramanga (UNAB), Colombia. 0000-0003-0751-8075
7 General Physician, Universidad del Sinú de Montería, Colombia.
8 Intern Physician, Universidad Autónoma de Bucaramanga (UNAB), Colombia. 0000-0002-6933-7635
9 General Physician, Universidad Libre de Barranquilla, Colombia.
Review Article
World Journal of Advanced Research and Reviews, 2022, 13(03), 507–512
Publication history:
Received on 21 January 2022; revised on 27 March 2022; accepted on 29 March 2022
Abstract:
Aerosol therapy is a form of drug administration that favors a rapid and easy absorption of the same in the respiratory tract; thus favoring great advantages in improving the health status of patients who are subjected to mechanical ventilation in the ICU. The most commonly used drugs are beta-agonist and anticholinergic bronchodilators. The use of this therapy should be used more frequently in these patients, but factors specific to the individual and the drug should be considered for its application; its use in patients with covid-19 should also be considered.
Keywords:
Aerosol therapy; Mechanic ventilation; Covid-19; ICU.
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0